Bliss GVS Pharma turns volatile, rebounds from day's low

The stock moved higher by 8% to Rs 174, bouncing back 35% from its intra-day low of Rs 129 on BSE

Bliss GVS Pharma rebounds over 30% from day’s low on heavy volumes
SI Reporter Mumbai
Last Updated : Jun 07 2017 | 2:05 PM IST
Bliss GVS Pharma gained 8% to Rs 174, bouncing back 35% from its intra-day low, on back of heavy volumes.

The stock opened 20% lower at Rs 129, after falling 20% on Tuesday. It close at Rs 161 on June 6, 2017.

The pharmaceuticals company yesterday after market hours  said there is no sensitive news to disseminate relating to stock of the company.

The company is doing its business as per business prudence on a normal basis, it added.

Bliss GVS Pharma said it noticed a negative comment about the promoter posted by an unknown person in moneycontrol public portal is false and baseless.

In past one-year, the stock had zoomed 123% as compared to 17% rise in the S&P BSE Sensex till Monday.

The trading volumes on the counter jumped more than five-fold with a combined 8.27 million shares representing 8% of total equity of Bliss GVS Pharma have changed hands on the NSE and BSE.

At 2:00 pm the stock was trading flat, up 1.8% at Rs 163.7 as compared to 0.06% rise in BSE Sensex.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story